Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autore principale: | Tanisha, Mehrin Haque |
---|---|
Altri autori: | Kabir, Eva Rahman |
Natura: | Tesi |
Lingua: | English |
Pubblicazione: |
Brac University
2021
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/15533 |
Documenti analoghi
-
CAR-T cell Therapy in B-cell Lymphoma
di: Faruk, Asef
Pubblicazione: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
di: Alam, Kazi Tasnuva
Pubblicazione: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
di: Tania, Umme
Pubblicazione: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
di: Moya, Amena Khatun
Pubblicazione: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
di: Tania, Umme
Pubblicazione: (2021)